You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HER2 Mutations

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lung Cancer, Non-squamous, Non-small Cell Trial (zongertinib, pembrolizumab, cisplatin)

Not yet recruiting
  • Lung Cancer, Non-squamous, Non-small Cell
  • (no location specified)
Nov 22, 2023

Breast Cancer, Ovarian Cancer, Breast Tumors Trial in Dnipro, Kyiv (Axitinib)

Enrolling by invitation
  • Breast Cancer
  • +7 more
  • Dnipro, Ukraine
  • +1 more
Jun 17, 2023

HER2-positive Breast Cancer Trial in Rome (PIK3CA analysis)

Active, not recruiting
  • HER2-positive Breast Cancer
  • PIK3CA analysis
  • Rome, RM, Italy
    Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Feb 20, 2023

NSCLC, NSCLC, Carcinoma, Bronchogenic Trial in Worldwide (Furmonertinib)

Recruiting
  • Non-Small Cell Lung Cancer
  • +14 more
  • Glendale, California
  • +12 more
Feb 2, 2023

NSCLC Trial in Winter Haven (Poziotinib, Docetaxel)

Suspended
  • NSCLC
  • Winter Haven, Florida
    Bond Clinic, P.A.
Jan 27, 2023

Recurrent/Advanced Gastric Cancer Trial in Seoul (Chemotherapy)

Not yet recruiting
  • Recurrent/Advanced Gastric Cancer
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Aug 22, 2022

NSCLC, NSCLC, EGFR/HER2 Exon 20 Insertion Mutation Trial in Fairfax (STX-721)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • +2 more
  • Fairfax, Virginia
    NEXT Virginia
Sep 18, 2023

HER2 Mutant NSCLC Trial (Pyrotinib maleate)

Not yet recruiting
  • HER2 Mutant Non-small Cell Lung Cancer
  • Pyrotinib maleate
  • (no location specified)
Jun 6, 2022

NSCLC Trial in Worldwide (Afatinib)

Completed
Has Results
  • NSCLC
  • Köln, Germany
  • +4 more
Aug 23, 2022

Among Talazoparib-Treated HER2-Negative mBC With gBRCA1/2m

Completed
  • Metastatic Breast Cancer
  • Breast Neoplasms
  • New York, New York
    Pfizer Inc.
Aug 5, 2022

Homologous Recombination-related Genesmutationsand HRD in Breast

Not yet recruiting
  • Breast Cancer
  • HER2-low Breast Cancer
  • Standard Management
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Jul 18, 2022

Gene Mutations in Triple-negative and HER2+ Breast Cancer

Active, not recruiting
  • Breast Cancer
    • Athens, Greece
      George Fountzilas
    Mar 15, 2022

    Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Afatinib

    Active, not recruiting
    • Advanced Lymphoma
    • +5 more
    • Afatinib Dimaleate
    • Philadelphia, Pennsylvania
      ECOG-ACRIN Cancer Research Group
    Jun 28, 2022

    Early HER2-negative High-risk Breast Cancer and BRCA1/2

    Not yet recruiting
    • Breast Cancer
      • Arkhangelsk, Russian Federation
      • +19 more
      Jul 3, 2023

      Breast Cancer Metastatic Trial in Beijing (TSL-1502 capsules(low dose), TSL-1502 capsules(high dose), Investigator's choice of

      Not yet recruiting
      • Breast Cancer Metastatic
      • TSL-1502 capsules(low dose)
      • +2 more
      • Beijing, China
        Cancer Hospital, Chinese Academy of Medical Sciences
      Jun 13, 2022

      Breast Cancer Stage IV Trial in Nice, Villejuif (Alpelisib, Ribociclib)

      Not yet recruiting
      • Breast Cancer Stage IV
      • Nice, France
      • +1 more
      Nov 14, 2022

      HER2-negative Breast Cancer, Metastatic Breast Cancer, Triple Negative Breast Cancer Trial in Spain (Olaparib)

      Recruiting
      • HER2-negative Breast Cancer
      • +2 more
      • Barcelona, Spain
      • +4 more
      Apr 14, 2022

      Tolerability Outcomes of Alpelisib in Real-world

      Recruiting
      • Breast Cancer
      • alpelisib plus fulvestrant
      • Mumbai, Maharashtra, India
      • +3 more
      Jun 8, 2022

      Everolimus-containing Chemotherapy in HER2- mBC PI3K/AKT/mTOR

      Completed
      • Breast Cancer
      • +2 more
      • No intervention, it was a retrospective study.
      • Hangzhou, Zhejiang, China
        Zhejiang Cancer Hospital
      Sep 13, 2021

      Breast Cancer, Colorectal Cancer, Solid Tumor Trial in Long Beach (Poziotinib Hydrochloride, Loperamide)

      Recruiting
      • Breast Cancer
      • +3 more
      • Poziotinib Hydrochloride
      • Long Beach, California
        Pacific Shores Medical Group
      Jun 14, 2021

      Advanced Solid Tumors With HER2 Mutation,eg:Colorectal,Urothelial,Gastric,

      Active, not recruiting
      • Advanced Solid Tumors With HER2 Mutation,eg:Colorectal,Urothelial,Gastric, Hepatobiliary,Endometrial,Melanoma,Ovarian,Cervical,Salivary Gland,Pancreatic,Breast
      • Trastuzumab deruxtecan
      • Santa Rosa, California
      • +29 more
      Jun 14, 2022

      Breast Cancer Trial in Worldwide (Neoadjuvant Olaparib monotherapy group, Neoadjuvant combination therapy with olaparib plus

      Not yet recruiting
      • Breast Cancer
      • Neoadjuvant Olaparib monotherapy group
      • Neoadjuvant combination therapy with olaparib plus durvalumab
      • Wien, Austria
      • +6 more
      Aug 10, 2022

      HER-Seq: A Blood-based Screening Study to Identify HER2

      Terminated
      • Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer
      • Metastatic Cervical Cancer
      • Almac HER-Seq Assay
      • Pittsburgh, Pennsylvania
      • +21 more
      May 17, 2021

      Solid Tumor, Haematological Malignancy, Colorectal Tumors Trial in United Kingdom (Trastuzumab, Pertuzumab)

      Recruiting
      • Solid Tumor
      • +10 more
      • Belfast, United Kingdom
      • +25 more
      Mar 28, 2023

      US Talazoparib-Treated Locally Advanced or Metastatic Breast

      Completed
      • Breast Cancer
      • New York, New York
        Pfizer Inc
      Nov 22, 2021